---
schema_version: "secwatch.filing_event.v1"
accession: "0001000228-23-000041"
form_type: "8-K"
ticker: "HSIC"
cik: "0001000228"
company_name: "HENRY SCHEIN INC"
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T03:35:25.592342+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Henry Schein Q2 GAAP EPS $1.06, Non-GAAP $1.31; Revenue $3.1B; Affirms FY Guidance

## Summary
- GAAP net income $140M ($1.06/diluted share) vs Q2 2022 $160M ($1.16); non-GAAP $173M ($1.31) vs $179M ($1.30).
- Total sales $3.1B (+2.3%); internal sales ex-PPE/COVID test kits +3.3% in local currencies; global dental +5.6% to $2.0B.
- PPE & COVID test kit sales $163M, down $96M YoY; impact on EPS estimated at $0.08/diluted share.
- FY 2023 non-GAAP EPS guidance reaffirmed at $5.18-$5.35; PPE sales now expected to decline 25%-30% (prior ~20-25%).
- Committed over $1B to acquisitions YTD; closed new $750M credit facility in July 2023.

## SEC filing metadata
- accession: 0001000228-23-000041
- form_type: 8-K
- ticker: HSIC
- cik: 0001000228
- company_name: HENRY SCHEIN INC
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000228/000100022823000041/0001000228-23-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000228/000100022823000041/hsic-20230807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001000228-23-000041
- JSON: https://secwatch.observer/filing/0001000228-23-000041.json
- Plain text: https://secwatch.observer/filing/0001000228-23-000041.txt

## Key facts
- Earnings Releases
  HENRY SCHEIN INC reported the six months ended July 1, 2023 results: revenue $6.2 billion. Guidance reaffirmed.
  - Period: the six months ended July 1, 2023
  - Revenue: $6.2 billion
  - Guidance: reaffirmed
  - Result: reported results
  source text: solutions, and by revenue cycle management solutions driven by a higher volume of e-claims. Year -to-Date Financial Results ● Total net sales for the first half of 2023 were $6.2 billion, a decrease of 0.8% compared with the first half of 2022. The 0.8% decrease included a 2.0% internal decrease in local currencies, 2.2% growth from acquisitions, and a 1.0%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1000228/000100022823000041/0001000228-23-000041-index.htm
- Earnings Releases
  HENRY SCHEIN INC reported the second quarter ended July 1, 2023 results: revenue $3.1 billion, net income $140 million, EPS $1.06 per diluted share. Guidance reaffirmed.
  - Period: the second quarter ended July 1, 2023
  - Revenue: $3.1 billion
  - Net income: $140 million
  - EPS: $1.06 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: Schein’s leadership in the markets that we serve and to deliver long-term sustainable shareholder value.” Second-Quarter Financial Results ● Total net sales for the quarter were $3.1 billion, an increase of 2.3% compared with the second quarter of 2022. The 2.3% increase included a 0.2% decrease in local currencies excluding acquisitions, 2.9% growth from
  evidence_url: https://www.sec.gov/Archives/edgar/data/1000228/000100022823000041/0001000228-23-000041-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.